We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
Cap. Flow
-$61.1M
Cap. Flow %
-3.78%
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.14M
2
AVGO icon
Broadcom
AVGO
+$3.01M
3
TSLA icon
Tesla
TSLA
+$2.23M
4
TWST icon
Twist Bioscience
TWST
+$1.76M
5
NVAX icon
Novavax
NVAX
+$1.74M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.2M
2
DHR icon
Danaher
DHR
+$17.1M
3
AMGN icon
Amgen
AMGN
+$12.4M
4
GILD icon
Gilead Sciences
GILD
+$9.52M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 33.28%
2 Healthcare 16.86%
3 Consumer Discretionary 11.45%
4 Communication Services 8.63%
5 Energy 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNAP icon
301
Snap
SNAP
$7.32B
$994K 0.06%
88,714
-12,954
-13% -$136K
TGT icon
302
Target
TGT
$62.1B
$991K 0.06%
5,985
-1,369
-19% -$225K
FE icon
303
FirstEnergy
FE
$28.9B
$988K 0.06%
24,675
-1,387
-5% -$56K
SAP icon
304
SAP
SAP
$187B
$985K 0.06%
7,784
+593
+8% +$69.6K
CLDX icon
305
Celldex Therapeutics
CLDX
$2.77B
$985K 0.06%
+27,372
New +$1.18M
CB icon
306
Chubb
CB
$140B
$981K 0.06%
5,050
+317
+7% +$66.6K
RGLD icon
307
Royal Gold
RGLD
$17.1B
$980K 0.06%
7,555
-707
-9% -$87.1K
SCHW
308
Charles Schwab
SCHW
$177B
$972K 0.06%
18,560
+1,216
+7% +$89K
IMGN
309
DELISTED
Immunogen Inc
IMGN
$971K 0.06%
+252,826
New +$1.08M
DTE icon
310
DTE Energy
DTE
$31.1B
$963K 0.06%
8,795
-496
-5% -$55.6K
CERE
311
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$959K 0.06%
+39,316
New +$1.15M
RCKT icon
312
Rocket Pharmaceuticals
RCKT
$348M
$951K 0.06%
+55,516
New +$1.09M
DOCU
313
DocuSign
DOCU
$9.63B
$950K 0.06%
16,293
-5,137
-24% -$306K
JAZZ icon
314
Jazz Pharmaceuticals
JAZZ
$15.9B
$947K 0.06%
6,475
-532
-8% -$78.7K
BLUE
315
DELISTED
bluebird bio
BLUE
$945K 0.06%
+14,851
New +$1.7M
IMVT icon
316
Immunovant
IMVT
$8.09B
$938K 0.06%
+60,489
New +$1.05M
HUM icon
317
Humana
HUM
$46.7B
$934K 0.06%
1,923
-130
-6% -$64.3K
SWKS icon
318
Skyworks Solutions
SWKS
$9.06B
$933K 0.06%
7,906
+1,592
+25% +$176K
PPL
319
PPL Corp
PPL
$27.3B
$930K 0.06%
33,449
-1,867
-5% -$52.9K
KRYS icon
320
Krystal Biotech
KRYS
$9.88B
$927K 0.06%
+11,581
New +$910K
PBR.A icon
321
Petrobras Class A
PBR.A
$107B
$922K 0.06%
99,314
-3,647
-4% -$35.2K
LSCC icon
322
Lattice Semiconductor
LSCC
$17.6B
$921K 0.06%
9,643
+723
+8% +$59.5K
EDIT icon
323
Editas Medicine
EDIT
$399M
$912K 0.06%
+125,742
New +$1.12M
BHVN icon
324
Biohaven
BHVN
$2.16B
$902K 0.06%
+66,008
New +$1.05M
AMX icon
325
America Movil
AMX
$78.1B
$901K 0.06%
42,806
-25
-0.1% -$513
11 12
13
14 15

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.

  • Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
  • Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
  • Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
  • Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
  • Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
  • Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.